Patents by Inventor Simon Enarsson

Simon Enarsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250032435
    Abstract: The invention provides a first concentrate comprising lactate and calcium ions, said first concentrate having increased stability against precipitation at temperatures around +4° C., said first concentrate being useful for preparing a ready-to-use dialysis fluid by mixing said first concentrate with water and optionally a second concentrate comprising glucose, wherein that the lactate concentration Lconc (expressed in moles per litre, M) of the concentrate fulfills the conditions: a ) ? L conc > 0.8 M ; and b ) ? L conc < ( 1.9 - 0.4 × Ca ready ) ? M ; and wherein Caready is the calcium concentration of the ready-to-use dialysis fluid expressed in millimoles per litre (mM).
    Type: Application
    Filed: October 10, 2024
    Publication date: January 30, 2025
    Inventors: Anders Wieslander, Ola Carlsson, Karin Sandin, Simon Enarsson, Viktoria Hancock
  • Patent number: 12144790
    Abstract: The invention provides a first concentrate comprising lactate and calcium ions, said first concentrate having increased stability against precipitation at temperatures around +4° C., said first concentrate being useful for preparing a ready-to-use dialysis fluid by mixing said first concentrate with water and optionally a second concentrate comprising glucose, wherein that the lactate concentration Lconc (expressed in moles per litre, M) of the concentrate fulfills the conditions: a) Lconc>0.8 M; and b) Lconc<(1.9?0.4×Caready) M; and wherein Caready is the calcium concentration of the ready-to-use dialysis fluid expressed in millimoles per litre (mM).
    Type: Grant
    Filed: May 5, 2017
    Date of Patent: November 19, 2024
    Assignee: Gambro Lundia AB
    Inventors: Anders Wieslander, Ola Carlsson, Karin Sandin, Simon Enarsson, Viktoria Hancock
  • Patent number: 10894119
    Abstract: The present invention concerns a system for preparing a ready-to-use peritoneal dialysis fluid. The system comprises a) a proportioning device; b) at least one source of water; c) at least one source of first concentrate adapted for connection with a) and b), d) at least one source of second concentrate adapted for connection with a) and b), and optionally, e) at least one source of further concentrate adapted for connection with a) and b), wherein the first concentrate comprises glucose and has a pH of between 1.5 and 4, and wherein the second concentrate comprises a physiologically acceptable buffer and has a pH of between 5.5 and 9.0.
    Type: Grant
    Filed: May 5, 2017
    Date of Patent: January 19, 2021
    Assignee: Gambro Lundia AB
    Inventors: Anders Wieslander, Olof Jansson, Ola Carlsson, Sture Hobro, Karin Sandin, Simon Enarsson
  • Publication number: 20190151265
    Abstract: The invention provides a first concentrate comprising lactate and calcium ions, said first concentrate having increased stability against precipitation at temperatures around +4° C., said first concentrate being useful for preparing a ready-to-use dialysis fluid by mixing said first concentrate with water and optionally a second concentrate comprising glucose, wherein that the lactate concentration Lconc (expressed in moles per litre, M) of the concentrate fulfills the conditions: a) Lconc>0.8 M; and b) Lconc<(1.9?0.4×Caready) M; and wherein Caready is the calcium concentration of the ready-to-use dialysis fluid expressed in millimoles per litre (mM).
    Type: Application
    Filed: May 5, 2017
    Publication date: May 23, 2019
    Inventors: Anders Wieslander, Ola Carlsson, Karin Sandin, Simon Enarsson, Viktoria Hancock
  • Publication number: 20190151526
    Abstract: The present invention concerns a system for preparing a ready-to-use peritoneal dialysis fluid. The system comprises a) a proportioning device; b) at least one source of water; c) at least one source of first concentrate adapted for connection with a) and b), d) at least one source of second concentrate adapted for connection with a) and b), and optionally, e) at least one source of further concentrate adapted for connection with a) and b), wherein the first concentrate comprises glucose and has a pH of between 1.5 and 4, and wherein the second concentrate comprises a physiologically acceptable buffer and has a pH of between 5.5 and 9.0.
    Type: Application
    Filed: May 5, 2017
    Publication date: May 23, 2019
    Inventors: Anders Wieslander, Olof Jansson, Ola Carlsson, Sture Hobro, Karin Sandin, Simon Enarsson